Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bioinformatic profiling identifies the glutaminase to be a potential novel cuproptosis-related biomarker for glioma

9 Sept 2022

Abstract excerpt

Glioma is the most common tumour of the central nervous system, with a poor prognosis and an increasing trend of incidence in recent years; it is also beginning to affect younger age groups more. Added to this, cuproptosis is a new form of cell death. Indeed, when a certain amount of copper accumulates in a cell, it affects specific mitochondrial metabolic enzymes in that cell and leads to cell death-a phenomenon...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36158220
DOI: 10.3389/fcell.2022.982439

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bioinformatic profiling identifies the glutaminase to be a potential novel cuproptosis-related biomarker for gliomaPMID 36158220Read ↗

Copper homeostasis based on Cuproptosis-related signature optimizes molecular subtyping and treatment of gliomaSemantic proximity Read ↗

Identification of cuproptosis-related subtypes and the development of a prognostic model in gliomaSemantic proximity Read ↗

The cuproptosis-related signature associated with the tumor environment and prognosis of patients with gliomaSemantic proximity Read ↗

A novel cuprotosis-related lncRNA signature effectively predicts prognosis in glioma patientsSemantic proximity Read ↗

Cuproptosis-related genes score: A predictor for hepatocellular carcinoma prognosis, immunotherapy efficacy, and metabolic reprogrammingSemantic proximity Read ↗

EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastomaSemantic proximity Read ↗

Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.Semantic proximity Read ↗

Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in gliomaSemantic proximity Read ↗

Identification of a copper metabolism‐related gene signature for predicting prognosis and immune response in gliomaSemantic proximity Read ↗

Cuproptosis-Associated Long Noncoding RNAs as Prognostic Markers in Glioma PatientsSemantic proximity Read ↗

A pan-cancer analysis of the glutaminase and their association with prognosis, tumor microenvironment, and therapeutic targetsSemantic proximity Read ↗

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.